Topline data were announced from a phase 3 trial evaluating bemarituzumab plus chemotherapy in individuals with gastric or gastroesophageal junction cancer with FGFR2b overexpression.

A total of 27.2 million people of all ages were uninsured in 2024, marking a nonsignificant increase from 25.0 million in 2023.

Participants could not effectively distinguish between medical responses written by a medical doctor and those written by an AI language model.

Perioperative durvalumab in combination with FLOT leads to significantly improved survival among individuals with resectable gastric and GEJ cancer.

Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.

Individuals with MASLD with a lean vs nonlean body type have increased mortality and cardiovascular disease, among other outcomes.

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

The woman tapped to lead the US CDC dodged key questions about recent cuts to the agency during a Senate hearing.

There is a significant prevalence of fibrosis among adults with SLD, especially among individuals with severe obesity and high alcohol consumption.

The NIH has stopped canceling biomedical research grants after a federal judge said hundreds of those cuts were illegal.

Topline data were announced from a trial evaluating zanzalintinib plus atezolizumab in adults with previously treated non-MSI-high mCRC.

Type 1 diabetes risk was elevated among patients with celiac disease, hypothyroidism, or hyperthyroidism vs control patients.